应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
GCVRZ Sanofi
退市 09-03 16:00:00 EDT
0.8711
+0.0000
0.00%
最高
0.8711
最低
0.8711
成交量
0.00
今开
0.8711
昨收
0.8711
日振幅
0.00%
总市值
10.92亿
流通市值
9.71亿
总股本
12.54亿
成交额
0.00
换手率
0.00%
流通股本
11.15亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
赛诺菲宣布将Xfg蛋白Nuvaxovid疫苗作为其2026-27年度全球唯一新冠产品进行生产
美股速递 · 05-28
赛诺菲宣布将Xfg蛋白Nuvaxovid疫苗作为其2026-27年度全球唯一新冠产品进行生产
中国生物制药(01177)与Sanofi就罗伐昔替尼订立独家授权协议
智通财经 · 03-04
中国生物制药(01177)与Sanofi就罗伐昔替尼订立独家授权协议
Sanofi(SNY.US):2024年Q4财报实现营收112.75亿美元,前值为117.53亿美元,预期值为105.7亿美元;每股收益为0.70美元,前值为0.89美元,预期值为0.74美元。
金融界 · 2025-01-30
Sanofi(SNY.US):2024年Q4财报实现营收112.75亿美元,前值为117.53亿美元,预期值为105.7亿美元;每股收益为0.70美元,前值为0.89美元,预期值为0.74美元。
加载更多
公司概况
公司名称:
Sanofi
所属市场:
NASDAQ
上市日期:
--
主营业务:
Sanofi于1994年根据法国法律注册成立。该公司是一家全球领先的医疗保健公司,专注于患者需求并从事治疗解决方案的研究、开发、制造和营销。该公司的活动围绕以下类别组织:DUPIXENT、神经病学&免疫学、罕见病、肿瘤学、罕见血液病、普药核心资产和非核心资产、疫苗、CHC。
发行价格:
--
{"stockData":{"symbol":"GCVRZ","market":"US","secType":"STK","nameCN":"Sanofi","latestPrice":0.8711,"timestamp":1788465600000,"preClose":0.8711,"halted":4,"volume":0,"delay":0,"changeRate":0,"floatShares":1114622547,"shares":1254041488,"eps":2.519335,"marketStatus":"退市","change":0,"latestTime":"09-03 16:00:00 EDT","open":0.8711,"high":0.8711,"low":0.8711,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":2.519335,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1788508800000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":0.8711,"dividendRate":4.027632,"volumeRatio":0},"requestUrl":"/m/hq/s/GCVRZ","defaultTab":"news","newsList":[{"id":"1129861349","title":"赛诺菲宣布将Xfg蛋白Nuvaxovid疫苗作为其2026-27年度全球唯一新冠产品进行生产","url":"https://stock-news.laohu8.com/highlight/detail?id=1129861349","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1129861349?lang=zh_cn&edition=full","pubTime":"2026-05-28 20:21","pubTimestamp":1779970899,"startTime":"0","endTime":"0","summary":"赛诺菲在简报文件中表示,已确定将Xfg蛋白Nuvaxovid疫苗作为公司在2026-27年度全球范围内唯一的新冠疫苗产品进行生产制造。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4139","GCVRZ","NVAX","BK4547","BK4568","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616774663","title":"中国生物制药(01177)与Sanofi就罗伐昔替尼订立独家授权协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2616774663","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2616774663?lang=zh_cn&edition=full","pubTime":"2026-03-04 06:19","pubTimestamp":1772576365,"startTime":"0","endTime":"0","summary":"智通财经APP讯,中国生物制药 公布,集团附属公司正大天晴药业集团股份有限公司已与Sanofi S.A.的一间全资附属公司就集团的JAK/ROCK抑制剂罗伐昔替尼在全球的开发、生产及商业化订立独家授权协议。根据协议条款,该集团将授予Sanofi在全球范围内开发、生产及商业化罗伐昔替尼的独家许可。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1409708.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK1521","HK0000165453.HKD","BK1589","BK1515","01177","IE00BZ08YT58.USD","IE00BZ08YR35.GBP","SNYNF","BK4007","IE00BZ08YS42.EUR","GCVRZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507107986","title":"Sanofi(SNY.US):2024年Q4财报实现营收112.75亿美元,前值为117.53亿美元,预期值为105.7亿美元;每股收益为0.70美元,前值为0.89美元,预期值为0.74美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2507107986","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507107986?lang=zh_cn&edition=full","pubTime":"2025-01-30 17:13","pubTimestamp":1738228394,"startTime":"0","endTime":"0","summary":"Sanofi(SNY.US):2024年Q4财报实现营收112.75亿美元,前值为117.53亿美元,预期值为105.7亿美元;每股收益为0.70美元,前值为0.89美元,预期值为0.74美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/30171347906752.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["SNY","GCVRZ","SNYNF"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sanofi.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0012},{"period":"1month","weight":0.0099},{"period":"3month","weight":0.0107},{"period":"6month","weight":0.138},{"period":"1year","weight":0.1951},{"period":"ytd","weight":0.1221}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Sanofi于1994年根据法国法律注册成立。该公司是一家全球领先的医疗保健公司,专注于患者需求并从事治疗解决方案的研究、开发、制造和营销。该公司的活动围绕以下类别组织:DUPIXENT、神经病学&免疫学、罕见病、肿瘤学、罕见血液病、普药核心资产和非核心资产、疫苗、CHC。","exchange":"NASDAQ","name":"Sanofi","nameEN":"Sanofi SA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Sanofi(GCVRZ)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Sanofi(GCVRZ)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Sanofi,GCVRZ,Sanofi股票,Sanofi股票老虎,Sanofi股票老虎国际,Sanofi行情,Sanofi股票行情,Sanofi股价,Sanofi股市,Sanofi股票价格,Sanofi股票交易,Sanofi股票购买,Sanofi股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Sanofi(GCVRZ)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Sanofi(GCVRZ)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}